Inscription Capital’s AB InBev BUD Stock Holding History

Inscription Capital’s Portfolio BUD Stock Details BUD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,387	Closed	-$244K	–	230
2021 Q2	$244K	Buy	+3,387	New	+$247K	0.03%	283

Other funds holding BUD

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BCF

BLS Capital Fondsmaeglerselskab Klampenborg, Denmark $2.94B AUM 13.53% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CCP

Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return

Inscription Capital's BUD Position: Q3 2021 in Review

Inscription Capital sold out of AB InBev (BUD) in Q3 2021, closing a stake of 3,387 shares — an estimated $244K sold.

Inscription Capital first reported a position in BUD in Q2 2021 and held it in 1 quarter. The position peaked at $244K in Q2 2021. 469 funds tracked by Wall St. Rank hold BUD as of Q3 2021.

Inscription Capital reported no remaining AB InBev position as of Q3 2021 after selling out during the quarter.
Inscription Capital sold 3,387 AB InBev shares in Q3 2021, an estimated $244K.
Inscription Capital first reported a position in AB InBev in Q2 2021 and held it in 1 quarter.
Inscription Capital's AB InBev position peaked at $244K in Q2 2021.
469 funds tracked by Wall St. Rank held AB InBev as of Q3 2021.

Based on Inscription Capital's 13F filing for Q3 2021, filed 9 Nov 2021.